CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 232 filers reported holding CANTEL MEDICAL CORP in Q3 2017. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,296,000 | +14.1% | 191,578 | +12.7% | 0.01% | +10.0% |
| Q4 2020 | $13,408,000 | +87.3% | 170,014 | +4.4% | 0.01% | +66.7% |
| Q3 2020 | $7,158,000 | +12.9% | 162,907 | +13.7% | 0.01% | 0.0% |
| Q2 2020 | $6,338,000 | -63.7% | 143,298 | -70.5% | 0.01% | -68.4% |
| Q1 2020 | $17,465,000 | -39.6% | 486,534 | +19.3% | 0.02% | -20.8% |
| Q4 2019 | $28,918,000 | +147.6% | 407,867 | +161.3% | 0.02% | +140.0% |
| Q3 2019 | $11,677,000 | -7.9% | 156,111 | -0.7% | 0.01% | -9.1% |
| Q2 2019 | $12,678,000 | +17.1% | 157,217 | -2.9% | 0.01% | +10.0% |
| Q1 2019 | $10,827,000 | -9.6% | 161,872 | +0.6% | 0.01% | -23.1% |
| Q4 2018 | $11,975,000 | -20.8% | 160,854 | -2.0% | 0.01% | 0.0% |
| Q3 2018 | $15,113,000 | -3.4% | 164,171 | +3.3% | 0.01% | -7.1% |
| Q2 2018 | $15,637,000 | -14.7% | 158,975 | -3.4% | 0.01% | -22.2% |
| Q1 2018 | $18,338,000 | -36.5% | 164,603 | -41.4% | 0.02% | -33.3% |
| Q4 2017 | $28,890,000 | +11.9% | 280,858 | +2.4% | 0.03% | +8.0% |
| Q3 2017 | $25,823,000 | +17.8% | 274,227 | -2.5% | 0.02% | +13.6% |
| Q2 2017 | $21,919,000 | -6.6% | 281,349 | -4.0% | 0.02% | -21.4% |
| Q1 2017 | $23,474,000 | +5.3% | 293,079 | +3.5% | 0.03% | 0.0% |
| Q4 2016 | $22,294,000 | +5.1% | 283,119 | +4.1% | 0.03% | 0.0% |
| Q3 2016 | $21,214,000 | +18.9% | 272,064 | +4.8% | 0.03% | +12.0% |
| Q2 2016 | $17,844,000 | -1.0% | 259,647 | +2.8% | 0.02% | -3.8% |
| Q1 2016 | $18,030,000 | +19.5% | 252,676 | +4.1% | 0.03% | +18.2% |
| Q4 2015 | $15,082,000 | +14.3% | 242,720 | +4.3% | 0.02% | +4.8% |
| Q3 2015 | $13,191,000 | +11.2% | 232,668 | +5.2% | 0.02% | +16.7% |
| Q2 2015 | $11,864,000 | +11.1% | 221,068 | -1.7% | 0.02% | +12.5% |
| Q1 2015 | $10,681,000 | +12.2% | 224,891 | +2.2% | 0.02% | +6.7% |
| Q4 2014 | $9,519,000 | +26.7% | 220,066 | +0.7% | 0.02% | +15.4% |
| Q3 2014 | $7,512,000 | -2.7% | 218,517 | +3.6% | 0.01% | 0.0% |
| Q2 2014 | $7,724,000 | -36.2% | 210,947 | -41.2% | 0.01% | -40.9% |
| Q1 2014 | $12,101,000 | +2.2% | 358,892 | +2.8% | 0.02% | 0.0% |
| Q4 2013 | $11,839,000 | +11.0% | 349,155 | +4.3% | 0.02% | 0.0% |
| Q3 2013 | $10,662,000 | +6.3% | 334,785 | +13.1% | 0.02% | 0.0% |
| Q2 2013 | $10,029,000 | – | 296,119 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|